Reference-based refinements
- PMID: 12719311
- PMCID: PMC153677
Reference-based refinements
Comment on
-
Pharmaceutical cost containment with reference-based pricing: time for refinements.CMAJ. 2002 Nov 26;167(11):1250-1. CMAJ. 2002. PMID: 12451080 Free PMC article. No abstract available.
Similar articles
-
Reference-based pricing.CMAJ. 2000 Jan 11;162(1):14; author reply 14,18. CMAJ. 2000. PMID: 11216190 Free PMC article. No abstract available.
-
New free trade agreement sparks fight over drug pricing.BMJ. 2005 Jan 29;330(7485):213. doi: 10.1136/bmj.330.7485.213-a. BMJ. 2005. PMID: 15677642 Free PMC article. No abstract available.
-
Merck Serono targets convenient, affordable medicines for patients at risk.Cardiovasc J Afr. 2009 Jan-Feb;20(1):77. Cardiovasc J Afr. 2009. PMID: 19287822 No abstract available.
-
[Fully possible to reduce the costs of hypertension treatment].Lakartidningen. 2009 Jun 3-9;106(23):1558-62. Lakartidningen. 2009. PMID: 19583013 Review. Swedish. No abstract available.
-
How market based pricing is failing Indian patients.BMJ. 2014 Jan 28;348:g278. doi: 10.1136/bmj.g278. BMJ. 2014. PMID: 24474222 Review. No abstract available.
References
-
- Canadian Institute for Health Information. Drug expenditures in Canada, 1985-2001. Ottawa: The Institute; 2002. p. 44, 92.
-
- Schneeweiss S, Walker AM, Glynn RJ, Maclure M, Dormuth C, Soumerai SB. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med 2002;346(11):822-9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources